At 48 weeks, the least-squares mean percentage change in body weight was -8.7% in the 1 mg group, -17.1% in the combined 4 mg group, -22.8% in the combined 8 mg group, and -24.2% in the 12 mg group, compared with -2.1% in the placebo group
No matter what challenges you may face on a GLP-1 medication, you are not alone
It represents the companys broader move into next-generation combination biology
When comparing Retatrutide vs Tirzepatide at equivalent dose-adjusted endpoints, the third receptor pathway consistently emerges as the differentiating factor in published research
Svarede til patienters forhbninger Der er flere mileple i Jens Juul Holsts lange karriere
These medications work by mimicking the action of naturally occurring GLP-1, an incretin hormone released by the intestine in response to food intake